1. Home
  2. Analysis
  3. Novalgin
  4. Anal-cancer-stage-0

Novalgin and Anal cancer stage 0 - a phase IV clinical study of FDA data

Summary:

Anal cancer stage 0 is reported as a side effect among people who take Novalgin (metamizole), especially for people who are male, 60+ old, also take Mcp, and have High blood pressure.

The phase IV clinical study analyzes which people have Anal cancer stage 0 when taking Novalgin. It is created by eHealthMe based on reports of 10,087 people who have side effects when taking Novalgin from the FDA, and is updated regularly.

What is Novalgin?

Novalgin has active ingredients of metamizole. It is often used in pain. eHealthMe is studying from 10,177 Novalgin users. Check the latest studies of Novalgin.

What is Anal cancer stage 0?

Anal cancer stage 0 is found to be associated with 35 drugs and 38 conditions by eHealthMe. Check the latest studies of Anal cancer stage 0.

On Jul, 26, 2026

10,087 people reported to have side effects when taking Novalgin.
Among them, 12 people (0.12%) have Anal cancer stage 0.

Could Novalgin cause Anal cancer stage 0?

Among these 12 people:

What is the gender of people who have Anal cancer stage 0 when taking Novalgin? *

  • female: 0.0 %
  • male: 100 %

What is the age of people who have Anal cancer stage 0 when taking Novalgin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

What are other drugs people take besides Novalgin? *

  1. Mcp: 10 people, 83.33%
  2. Valsartan: 4 people, 33.33%
  3. Temazepam: 4 people, 33.33%
  4. Ranitidine Hydrochloride: 4 people, 33.33%
  5. Ibuprofen: 4 people, 33.33%
  6. Zolpidem: 2 people, 16.67%
  7. Movicol: 1 person, 8.33%
  8. Ibu: 1 person, 8.33%
  9. Aubagio: 1 person, 8.33%

What are other side effects people have besides Anal cancer stage 0? *

  1. Anal Inflammation: 12 people, 100.00%
  2. Lymphocyte Count Decreased: 11 people, 91.67%
  3. Anal Pruritus (anal itching): 11 people, 91.67%
  4. Dyschezia (difficulty in defecating): 11 people, 91.67%
  5. Erythema Multiforme (a type of hypersensitivity reaction): 11 people, 91.67%
  6. C-Reactive Protein Increased: 11 people, 91.67%
  7. Fever: 11 people, 91.67%
  8. Anorectal Discomfort: 11 people, 91.67%
  9. Gastrointestinal Motility Disorder (abnormal intestinal contractions): 11 people, 91.67%
  10. Anal Ulcer: 11 people, 91.67%

What are the existing conditions these people have? *

  1. High Blood Pressure: 11 people, 91.67%
  2. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Novalgin and have Anal cancer stage 0?

- Check whether Anal cancer stage 0 is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Novalgin:

Anal cancer stage 0 treatments and more:

How severe was Anal cancer stage 0 and when was it recovered:

Expand to all the drugs that have ingredients of metamizole:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Novalgin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Anal cancer stage 0:

Browse all the conditions that are associated with Anal cancer stage 0:

How the study uses the data?

The study uses data from the FDA. It is based on metamizole (the active ingredients of Novalgin) and Novalgin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.